Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis-Reference-Cited by-同舟云学术

Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis

Published:2017-08-03 Issue:18 Volume:174 Page:3018-3031
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Pérez-Baos S¹²,Barrasa J I¹,Gratal P¹²,Larrañaga-Vera A¹²,Prieto-Potin I¹²,Herrero-Beaumont G¹²^ORCID,Largo R¹²

Affiliation:

1. Bone and Joint Research Unit, Rheumatology Department; IIS-Fundación Jiménez Díaz UAM; Madrid Spain

2. Thematic Network on Aging and Frailty (RETICEF); Madrid Spain

Funder

Instituto de Salud Carlos III

Pfizer

European Regional Development Fund

Pfizer Investigator Initiated Research (IIR) Competitive

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13932/fullpdf

Reference68 articles.

1. Apoptotic cells promote their own clearance and immune tolerance through activation of LXR;A-Gonzalez;Immunity,2009

2. The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors;Alexander;Br J Pharmacol,2015a

3. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015b

4. The Concise Guide to PHARMACOLOGY 2015/16: Transporters;Alexander;Br J Pharmacol,2015c

5. Post-transcriptional regulation of macrophage ABCA1, an early response gene to IFN-gamma;Alfaro Leon;Biochem Biophys Res Commun,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low remnant cholesterol and the subsequent risk of new-onset atrial fibrillation: A prospective cohort study;Heart Rhythm;2024-08

2. Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients;Frontiers in Pharmacology;2024-05-31

3. Cholesterol metabolism: physiological regulation and diseases;MedComm;2024-02

4. How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits;Current Rheumatology Reports;2023-12

5. Endothelial inflammation in patients with Rheumatoid Arthritis treated with Tofacitinib;2023-11-10